KALETRA Side Effects

6910258-2 | Coarctation Of The Aorta
on Jul 28, 2010 Male patient from , weighting 7.50 lb, was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: coarctation of the aorta. Kaletra dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6909552-0 | Intestinal Malrotation
Patient was taking Kaletra (View Usage). Patient had the following side effects: intestinal malrotation on Jul 29, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 6.83 lb, . Kaletra dosage: . During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ).

6901081-3 | Cataract Operation, Dyspepsia, Pneumonia, Proteinuria, Rash
Adverse event was reported on Aug 02, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: ) was diagnosed with oral fungal infection, antibiotic prophylaxis, dyspepsia, gastrointestinal disorder, influenza immunisation and. Location: KOREA, REPUBLIC OF , 55 years of age, weighting 141.1 lb, After Kaletra was administered, patient had the following side effects: cataract operation, dyspepsia, pneumonia (What is pneumonia?), proteinuria, rash (What is rash?). During the same period patient was treated with 3TC/AZT (View 3tc/azt Review and 3tc/azt Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), IPAROSIN (View Iparosin Review and Iparosin Label ), KUNWHA SOMALGEN (View Kunwha Somalgen Review and Kunwha Somalgen Label ), VARIDASE (View Varidase Review and Varidase Label ), DENOGAN (1g/5ml Vial) (View Denogan Review and Denogan Label ), MIYARISAN VITA (View Miyarisan-vita Review and Miyarisan-vita Label ), GREENCROSS INFLUENZA HA VACCINE (1ml Vial) (View Greencross Influenza Ha Vaccine Review and Greencross Influenza Ha Vaccine Label ). Patient was hospitalized.

6898072-8 | Axonal Neuropathy, Peripheral Sensory Neuropathy, Polyneuropathy
on Jul 23, 2010 Female patient from FRANCE , weighting 132.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: axonal neuropathy, peripheral sensory neuropathy, polyneuropathy. Kaletra dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.


6895890-7 | Aggression, Confusional State, Disorientation, Grand Mal Convulsion, Loss Of Consciousness, Sleep Phase Rhythm Disturbance
on Jul 23, 2010 Male patient from FRANCE , weighting 156.5 lb, was diagnosed with hiv infection (What is hiv infection?), dyslipidaemia, hypertension, embolism arterial, oesophagitis haemorrhagic, insomnia and was treated with Kaletra (View Usage). Patient had the following side effects: aggression, confusional state, disorientation, grand mal convulsion, loss of consciousness, sleep phase rhythm disturbance. Kaletra dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), PREVISCAN (View Previscan Review and Previscan Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized and became disabled.

6895296-0 | Pyelonephritis Acute
Patient was taking Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: pyelonephritis acute on Jul 23, 2010 from SPAIN Additional patient health information: Male patient , weighting 111.8 lb, was diagnosed with hiv infection (What is hiv infection?), lipoatrophy and. Kaletra dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ). Patient was hospitalized.

6888561-4 | Abortion Spontaneous
Adverse event was reported on Jul 26, 2010 by a Female patient taking Kaletra (View Usage) (Dosage: 4 Daily Dose) . Location: UNITED STATES , 36 years of age, Patient experienced the following unwanted or unexpected effects: abortion spontaneous. During the same period patient was treated with COMBIVIR (2 Daily Dose) (View Combivir Review and Combivir Label ), ATRIPLA (1 Daily Dose) (View Atripla Review and Atripla Label ).

6888556-0 | Anal Cancer, Papilloma Viral Infection
on Jul 22, 2010 Male patient from GERMANY , weighting 147.7 lb, was treated with Kaletra (View Usage). Patient had the following side effects: anal cancer (What is anal cancer?), papilloma viral infection. Kaletra dosage: .

6888540-7 | Asthenia, Back Pain, Decreased Appetite
on Jul 23, 2010 Male patient from FRANCE , weighting 172.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: asthenia, back pain (What is back pain?), decreased appetite. Kaletra dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

6884787-4 | Cataract Operation, Dyspepsia, Pneumonia, Proteinuria, Rash
Patient was taking Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: cataract operation, dyspepsia, pneumonia (What is pneumonia?), proteinuria, rash (What is rash?) on Jul 19, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 55 years of age, weighting 141.1 lb, was diagnosed with oral fungal infection, antibiotic prophylaxis, dyspepsia, gastrointestinal disorder, influenza immunisation and. Kaletra dosage: . During the same period patient was treated with 3TC/AZT (View 3tc/azt Review and 3tc/azt Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), IPAROSIN (View Iparosin Review and Iparosin Label ), KUNWHA SOMALGEN (View Kunwha Somalgen Review and Kunwha Somalgen Label ), VARIDASE (View Varidase Review and Varidase Label ), DENOGAN (1g/5ml Vial) (View Denogan Review and Denogan Label ), MIYARISAN VITA (View Miyarisan-vita Review and Miyarisan-vita Label ), GREENCROSS INFLUENZA HA VACCINE (1ml Vial) (View Greencross Influenza Ha Vaccine Review and Greencross Influenza Ha Vaccine Label ). Patient was hospitalized.

6884479-1 | Anaemia, Dysmorphism, Hypocalcaemia
Adverse event was reported on Jul 22, 2010 by a Female patient taking Kaletra (View Usage) (Dosage: ) . Location: FRANCE , weighting 5.86 lb, Patient had the following side effects: anaemia, dysmorphism, hypocalcaemia. During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ). Patient was hospitalized.

6882108-4 | Hepatic Cirrhosis, Hepatic Enzyme Increased
on Jul 21, 2010 Male patient from GERMANY , weighting 200.6 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: hepatic cirrhosis, hepatic enzyme increased. Kaletra dosage: 2x2. During the same period patient was treated with TRUVADA (1x1) (View Truvada Review and Truvada Label ).

6880891-5 | Premature Rupture Of Membranes
on Jul 23, 2010 Female patient from FRANCE , weighting 138.9 lb, was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: premature rupture of membranes. Kaletra dosage: . During the same period patient was treated with CONTRACEPTION (View Contraception Review and Contraception Label ).

6879755-2 | Abdominal Pain, Affect Lability, Aggression, Asthenia, Body Temperature Increased, Cerebral Atrophy, Cerebral Ventricle Dilatation, Cognitive Disorder, Computerised Tomogram Abnormal
Patient was taking Kaletra (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), affect lability, aggression, asthenia, body temperature increased, cerebral atrophy, cerebral ventricle dilatation, cognitive disorder, computerised tomogram abnormal on Jul 20, 2010 from GERMANY Additional patient health information: Male patient , weighting 123.5 lb, was diagnosed with hiv infection (What is hiv infection?) and. Kaletra dosage: 2x2 Per Os. During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ), MIRTAZEPAM (View Mirtazepam Review and Mirtazepam Label ), DELIX (Pause) (View Delix Review and Delix Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FERRONASOL DUODENAL (View Ferronasol Duodenal Review and Ferronasol Duodenal Label ). Patient was hospitalized.

6876469-X | Pre-eclampsia, Premature Labour
Adverse event was reported on Jul 19, 2010 by a Female patient taking Kaletra (View Usage) (Dosage: Tabs/caps) . Location: UNITED STATES , 33 years of age, After Kaletra was administered, patient had the following side effects: pre-eclampsia, premature labour. During the same period patient was treated with LEXIVA (View Lexiva Review and Lexiva Label ), COMBIVIR (Tabs/caps) (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (Tabs/caps) (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

6873669-X | Bipolar Disorder
on Jul 14, 2010 Male patient from KOREA, REPUBLIC OF , 37 years of age, was diagnosed with pneumonia (What is pneumonia?), antifungal prophylaxis, rhinorrhoea, productive cough, opportunistic infection prophylaxis and was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: bipolar disorder (What is bipolar disorder?). Kaletra dosage: . During the same period patient was treated with 3TC/AZT (900 Mg Daily) (View 3tc/azt Review and 3tc/azt Label ), MEIACT (View Meiact Review and Meiact Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (2 Tablets Daily) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), BROPHYLLINE CAPSULE 100 MG (View Brophylline Capsule 100 Mg Review and Brophylline Capsule 100 Mg Label ), LEVOTUSS (6mg/ml, 30 Ml Daily) (View Levotuss Review and Levotuss Label ), KLARICID (View Klaricid Review and Klaricid Label ). Patient was hospitalized.

6872130-6 | Deafness, Tinnitus
on Jul 15, 2010 Male patient from BRAZIL , weighting 119.0 lb, was diagnosed with hiv infection (What is hiv infection?), hypertension and was treated with Kaletra (View Usage). Patient had the following side effects: deafness, tinnitus (What is tinnitus?). Kaletra dosage: . During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6868188-0 | Dehydration, Hyperkalaemia, Hyponatraemia, Pneumonia
Patient was taking Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: dehydration, hyperkalaemia, hyponatraemia, pneumonia (What is pneumonia?) on Jul 16, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 47 years of age, weighting 97.00 lb, was diagnosed with prophylaxis, pneumocystis jiroveci pneumonia, prophylaxis of nausea and vomiting, hiv wasting syndrome (What is hiv wasting syndrome?), decreased appetite and. Kaletra dosage: . During the same period patient was treated with ABC (800mg Daily) (View Abc Review and Abc Label ), LAMIVUDINE (EPIVIR HBV) (300mg Daily) (View Lamivudine (epivir Hbv) Review and Lamivudine (epivir Hbv) Label ), SULFMETHOXAZOL, TRIMETHOPRIM (View Sulfmethoxazol, Trimethoprim Review and Sulfmethoxazol, Trimethoprim Label ), MACPERAN (3 Tablets Daily) (View Macperan Review and Macperan Label ), MEGACE (40mg/240ml) (View Megace Review and Megace Label ), TAEKUK DAPSONE (100mg Daily) (View Taekuk Dapsone Review and Taekuk Dapsone Label ). Patient was hospitalized.

6866716-2 | Anaemia, Diarrhoea, Haemoglobin Decreased, Leukopenia, Pneumonia, White Blood Cell Count Decreased
Adverse event was reported on Jul 12, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), antifungal prophylaxis, decreased appetite and. Location: KOREA, REPUBLIC OF , 65 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, diarrhoea, haemoglobin decreased, leukopenia, pneumonia (What is pneumonia?), white blood cell count decreased. During the same period patient was treated with ABC (600 Mg, Daily) (View Abc Review and Abc Label ), AZT(ZDV) (600 Mg, Daily) (View Azt(zdv) Review and Azt(zdv) Label ), LAMIVUDINE (EPIVIR HBV) (30 Mg, Daily) (View Lamivudine (epivir Hbv) Review and Lamivudine (epivir Hbv) Label ), COMBIVIR (2 Tablets, Daily) (View Combivir Review and Combivir Label ), DAPSONE (100mg X 1 Tablet Daily) (View Dapsone Review and Dapsone Label ), TS TAB (1 Tab, Daily) (View Ts Tab Review and Ts Tab Label ), ZIAGEN (2 Tablets, Daily) (View Ziagen Review and Ziagen Label ), MEGACE SUSPENSION 40MG/240ML (10 Ml, Daily) (View Megace Suspension 40mg/240ml Review and Megace Suspension 40mg/240ml Label ). Patient was hospitalized.

6863391-8 | Retinal Detachment
on Jul 12, 2010 Male patient from KOREA, REPUBLIC OF , weighting 187.4 lb, was diagnosed with cytomegalovirus chorioretinitis, antifungal prophylaxis and was treated with Kaletra (View Usage). Patient had the following side effects: retinal detachment. Kaletra dosage: . During the same period patient was treated with 3TC/AZT (View 3tc/azt Review and 3tc/azt Label ), VALCYTE (View Valcyte Review and Valcyte Label ), TS TAB (View Ts Tab Review and Ts Tab Label ). Patient was hospitalized.

6857301-7 | Priapism
on Jul 15, 2010 Male patient from UNITED STATES , 50 years of age, was diagnosed with hiv infection (What is hiv infection?), schizoaffective disorder, extrapyramidal disorder and was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: priapism. Kaletra dosage: . During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ), PERPHENAZINE (View Perphenazine Review and Perphenazine Label ), TRIZIVIR (300/150/300 Mg) (View Trizivir Review and Trizivir Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ).

6857300-5 | Pulmonary Tuberculosis
Patient was taking Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary tuberculosis on Jul 13, 2010 from BELGIUM Additional patient health information: Male patient , weighting 164.2 lb, was diagnosed with hiv infection (What is hiv infection?) and. Kaletra dosage: . During the same period patient was treated with TRUVADA (200/245 Mg Daily) (View Truvada Review and Truvada Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

6850341-3 | Bipolar Disorder
Adverse event was reported on Jul 08, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), antifungal prophylaxis, rhinorrhoea, productive cough and. Location: KOREA, REPUBLIC OF , 37 years of age, Patient had the following side effects: bipolar disorder (What is bipolar disorder?). During the same period patient was treated with 3TC/AZT (900 Mg Daily) (View 3tc/azt Review and 3tc/azt Label ), MELECT TAB 100 MG (View Melect Tab 100 Mg Review and Melect Tab 100 Mg Label ), TS (2 Tablets Daily) (View Ts Review and Ts Label ), BROPHYLLINE CAPSULE 100 MG (View Brophylline Capsule 100 Mg Review and Brophylline Capsule 100 Mg Label ), LEVOTUSS (6mg/ml, 30 Ml Daily) (View Levotuss Review and Levotuss Label ). Patient was hospitalized.

6848642-8 | Gastroschisis, Premature Baby
on Jul 07, 2010 Male patient from UNITED STATES , weighting 4.70 lb, was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: gastroschisis, premature baby. Kaletra dosage: . During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ).

6848031-6 | Acute Respiratory Distress Syndrome, Congenital Aortic Anomaly, Premature Baby, Tracheal Stenosis
on Jul 07, 2010 Male patient from FRANCE , weighting 3.11 lb, was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, congenital aortic anomaly, premature baby, tracheal stenosis. Kaletra dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), LAMICTAL (View Lamictal Review and Lamictal Label ).

6832893-2 | Gestational Hypertension
Patient was taking Kaletra (View Usage). Patient had the following side effects: gestational hypertension on Jul 02, 2010 from UNITED STATES Additional patient health information: Female patient , 36 years of age, was diagnosed with human immunodeficiency virus transmission, prophylaxis, gestational hypertension and. Kaletra dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), METHYLDOPA (View Methyldopa Review and Methyldopa Label ). Patient was hospitalized.

6831678-0 | Polydactyly, Premature Baby
Adverse event was reported on Jul 02, 2010 by a Female patient taking Kaletra (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 3.53 lb, After Kaletra was administered, patient had the following side effects: polydactyly, premature baby. During the same period patient was treated with RETROVIR (View Retrovir Review and Retrovir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6831018-7 | Pulmonary Tuberculosis
on Jul 02, 2010 Male patient from BELGIUM , weighting 164.2 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary tuberculosis. Kaletra dosage: . During the same period patient was treated with TRUVADA (200/245 Mg Daily) (View Truvada Review and Truvada Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

6831017-5 | Diarrhoea, Lipodystrophy Acquired
on Jul 05, 2010 Female patient from FRANCE , 31 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient had the following side effects: diarrhoea, lipodystrophy acquired. Kaletra dosage: 200mg/50mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ).

6828194-9 |
Patient was taking Kaletra (View Usage). on Jul 02, 2010 from BOTSWANA Additional patient health information: Female patient , 22 years of age, weighting 113.5 lb, was diagnosed with prophylaxis, human immunodeficiency virus transmission, hiv infection (What is hiv infection?) and. Kaletra dosage: . During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ). Patient was hospitalized.

6826923-1 |
Adverse event was reported on Jul 02, 2010 by a Female patient taking Kaletra (View Usage) (Dosage: ) was diagnosed with prophylaxis against hiv infection (What is prophylaxis against hiv infection?) and. Location: BOTSWANA , 22 years of age, weighting 113.5 lb, . During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ). Patient was hospitalized.

6809896-7 | Abortion Induced
on Jun 21, 2010 Female patient from THAILAND , 17 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient had the following side effects: abortion induced. Kaletra dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), COMBIVIR (600/300mg Daily) (View Combivir Review and Combivir Label ), VIREAD (View Viread Review and Viread Label ).

6803852-0 | Blighted Ovum
on Jun 23, 2010 Female patient from UNITED STATES , 29 years of age, was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: blighted ovum. Kaletra dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6801506-8 | Abortion Induced
Patient was taking Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced on Jun 24, 2010 from UNITED STATES Additional patient health information: Female patient , 36 years of age, . Kaletra dosage: . During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ).

6796410-8 | Aplastic Anaemia, Eye Disorder
Adverse event was reported on Jun 15, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: 200/50 2x2 Per Day) was diagnosed with hiv infection (What is hiv infection?), antifungal prophylaxis, depression (What is depression?), alcohol abuse and. Location: GERMANY , weighting 149.9 lb, Patient had the following side effects: aplastic anaemia, eye disorder. During the same period patient was treated with TRUVADA (200/245) (View Truvada Review and Truvada Label ), COTRIM (View Cotrim Review and Cotrim Label ), ISENTRESS (View Isentress Review and Isentress Label ), KIVEXA (View Kivexa Review and Kivexa Label ), PSYCHOTROPICS (View Psychotropics Review and Psychotropics Label ).

6796096-2 | Gastrointestinal Haemorrhage, Hiatus Hernia
on Jun 15, 2010 Male patient from FRANCE , weighting 163.1 lb, was diagnosed with hiv infection (What is hiv infection?), dyslipidaemia, hypertension, embolism, gastrointestinal haemorrhage, prophylaxis, insomnia and was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: gastrointestinal haemorrhage, hiatus hernia. Kaletra dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), PREVISCAN (View Previscan Review and Previscan Label ), MOPRAL (View Mopral Review and Mopral Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

6791411-8 | Diarrhoea, Lipodystrophy Acquired
on Jun 17, 2010 Female patient from FRANCE , 31 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, lipodystrophy acquired. Kaletra dosage: 200mg/50mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ).

6786571-9 | Pre-eclampsia, Premature Labour
Patient was taking Kaletra (View Usage). Patient had the following side effects: pre-eclampsia, premature labour on Jun 18, 2010 from UNITED STATES Additional patient health information: Female patient , 33 years of age, . Kaletra dosage: Tabs/caps. During the same period patient was treated with LEXIVA (View Lexiva Review and Lexiva Label ), COMBIVIR (Tabs/caps) (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (Tabs/caps) (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ).

6784889-7 | Abdominal Discomfort, Anaemia, Asthenia, Blood Glucose Abnormal, Confusional State, Cough, Dysphagia, Dyspnoea, Emphysema
Adverse event was reported on Jun 17, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: Daily 400/100mg, Unit 200mg/50mg, Form Strength 200 Mg/50 Mg) was diagnosed with hiv infection (What is hiv infection?) and. Location: BELGIUM , weighting 116.8 lb, After Kaletra was administered, patient had the following side effects: abdominal discomfort, anaemia, asthenia, blood glucose abnormal, confusional state, cough, dysphagia, dyspnoea, emphysema. During the same period patient was treated with RETROVIR (600/300mg Daily) (View Retrovir Review and Retrovir Label ). Patient was hospitalized.

6782524-5 | Gingival Bleeding, Thrombocytopenia
on Jun 11, 2010 Female patient from SPAIN , weighting 138.9 lb, was diagnosed with hepatitis c (What is hepatitis c?), hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: gingival bleeding, thrombocytopenia. Kaletra dosage: . During the same period patient was treated with PEG INTERFERON (View Peg-interferon Review and Peg-interferon Label ), RIBAVIRIN (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6780242-0 | Anaemia, Caesarean Section, Normal Newborn
on Jun 10, 2010 Female patient from UNITED KINGDOM , 26 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient had the following side effects: anaemia, caesarean section, normal newborn. Kaletra dosage: . During the same period patient was treated with SUSTIVA (View Sustiva Review and Sustiva Label ), TRUVADA (9-oct-2007 To 11-oct-2007) (View Truvada Review and Truvada Label ).

6773626-8 | Abdominal Discomfort, Anaemia, Asthenia, Blood Glucose Abnormal, Confusional State, Cough, Dysphagia, Dyspnoea, Emphysema
Patient was taking Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: abdominal discomfort, anaemia, asthenia, blood glucose abnormal, confusional state, cough, dysphagia, dyspnoea, emphysema on Jun 08, 2010 from BELGIUM Additional patient health information: Male patient , weighting 116.8 lb, was diagnosed with hiv infection (What is hiv infection?) and. Kaletra dosage: Daily 400/100mg, Unit 200mg/50mg, Form Strength 200 Mg/50 Mg. During the same period patient was treated with RETROVIR (600/300mg Daily) (View Retrovir Review and Retrovir Label ). Patient was hospitalized.

6765391-5 | Clinodactyly, Congenital Hand Malformation
Adverse event was reported on Jun 01, 2010 by a Female patient taking Kaletra (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 7.28 lb, Patient experienced the following unwanted or unexpected effects: clinodactyly, congenital hand malformation. During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), TRUVADA (View Truvada Review and Truvada Label ).

6764848-0 | Abortion Induced
on Jun 01, 2010 Female patient from UNITED KINGDOM , 26 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient had the following side effects: abortion induced. Kaletra dosage: .

6763993-3 | Gingival Bleeding, Thrombocytopenia
on May 31, 2010 Female patient from SPAIN , weighting 138.9 lb, was diagnosed with hepatitis c (What is hepatitis c?), hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: gingival bleeding, thrombocytopenia. Kaletra dosage: . During the same period patient was treated with PEG INTERFERON (View Peg-interferon Review and Peg-interferon Label ), RIBAVIRIN (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6763817-4 | Anaemia, Dysmorphism, Hypocalcaemia
Patient was taking Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, dysmorphism, hypocalcaemia on Jun 01, 2010 from FRANCE Additional patient health information: Female patient , weighting 5.86 lb, . Kaletra dosage: . During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ). Patient was hospitalized.

6763212-8 | Retroperitoneal Neoplasm, Thrombophlebitis
Adverse event was reported on May 31, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: SPAIN , weighting 127.9 lb, Patient had the following side effects: retroperitoneal neoplasm, thrombophlebitis.

6763127-5 | Sinus Disorder
on Jun 01, 2010 Male patient from GERMANY , weighting 174.2 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: sinus disorder. Kaletra dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

6763101-9 | Hip Dysplasia
on Jun 01, 2010 Female patient from BELGIUM , weighting 7.33 lb, was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: hip dysplasia. Kaletra dosage: .

6761729-3 | Anoxia, Bradycardia, Bruxism, C-reactive Protein Increased, Cardiac Hypertrophy, Coma, Encephalopathy, Foetal Arrhythmia
Patient was taking Kaletra (View Usage). Patient had the following side effects: anoxia, bradycardia, bruxism, c-reactive protein increased, cardiac hypertrophy, coma, encephalopathy, foetal arrhythmia on Jun 01, 2010 from FRANCE Additional patient health information: Female patient , weighting 6.61 lb, . Kaletra dosage: . During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ), TPN (View Tpn Review and Tpn Label ).